Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Merck Kgaa ADR (OP:MKKGY)

27.42 -0.83 (-2.94%)
Streaming Delayed Price Updated: 3:59 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 123,502
Open 27.50
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 28.25
Today's Range 27.26 - 27.54
52wk Range 27.19 - 39.17
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Top performing mid-cap stocks last week: WRD (+97.62%), GDS (+43.45%), SWTX (+42.58%), RXRX (+40.59%), SOC (+39.09%), WGS (+28.23%), VNET (+28.22%), NSP (+25.99%), CRSP (+25.21%), AXSM (+24.01%) 
Via Benzinga
Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics
Merck KGaA is in advanced talks to acquire SpringWorks, whose portfolio could bolster Merck's oncology business amid patent expirations and competition. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property

Performance

YTD
-4.4%
-4.4%
1 Month
-2.8%
-2.8%
3 Month
-4.0%
-4.0%
6 Month
-22.5%
-22.5%
1 Year
-21.7%
-21.7%

More News

Read More
GSK To Buy US-Based Stomach Cancer Drug Developer For Over $1 Billion
Via Benzinga
Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition
Via Benzinga
Germany's Merck To Launch Semiconductor Base In China
Via Benzinga
Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
Via Benzinga
Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
Via Benzinga
Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
Via Benzinga
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
Via Benzinga
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
Via Benzinga
Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
Via Benzinga
FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
Via Benzinga
Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
Via Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Via Benzinga
With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics
Via Benzinga
PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
Via Benzinga
Mersana Inks Cancer Therapy Development Deal With Merck Germany
Via Benzinga
SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
Via Benzinga
Germany's Merck Slapped With Formal French Investigation Related To Its Thyroid Drug
Via Benzinga
PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers
Via Benzinga
TSM Looks To Hire Over 8,000 People In 2022
Via Benzinga
Despite Palantir’s Impressive Deals, Its Losses and Valuation Make It Unappetizing
Via InvestorPlace
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
Via Benzinga
GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
Via Benzinga
Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
Via Benzinga

Frequently Asked Questions

Is Merck Kgaa ADR publicly traded?
Yes, Merck Kgaa ADR is publicly traded.
What exchange does Merck Kgaa ADR trade on?
Merck Kgaa ADR trades on the OTC Traded
What is the ticker symbol for Merck Kgaa ADR?
The ticker symbol for Merck Kgaa ADR is MKKGY on the OTC Traded
What is the current price of Merck Kgaa ADR?
The current price of Merck Kgaa ADR is 27.42
When was Merck Kgaa ADR last traded?
The last trade of Merck Kgaa ADR was at 03/31/25 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.